Yong Wan - Search Results

Year	Number of Results
2003	4
2004	5
2006	3
2007	5
2008	7
2009	7
2010	10
2011	11
2012	13
2013	15
2014	17
2015	21
2016	18
2017	11
2018	14
2019	18
2020	27
2021	9

1

Epithelial Mutations in Endometriosis: Link to Ovarian Cancer.

Bulun SE, Wan Y, Matei D. Bulun SE, et al. Among authors: wan y. Endocrinology. 2019 Mar 1;160(3):626-638. doi: 10.1210/en.2018-00794. Endocrinology. 2019. PMID: 30657901 Free PMC article. Review.

2

Targeting CD73 to augment cancer immunotherapy.

Roh M, Wainwright DA, Wu JD, Wan Y, Zhang B. Roh M, et al. Among authors: wan y. Curr Opin Pharmacol. 2020 Aug;53:66-76. doi: 10.1016/j.coph.2020.07.001. Epub 2020 Aug 7. Curr Opin Pharmacol. 2020. PMID: 32777746 Free article. Review.

3

CD73: an emerging checkpoint for cancer immunotherapy.

Chen S, Wainwright DA, Wu JD, Wan Y, Matei DE, Zhang Y, Zhang B. Chen S, et al. Among authors: wan y. Immunotherapy. 2019 Aug;11(11):983-997. doi: 10.2217/imt-2018-0200. Epub 2019 Jun 21. Immunotherapy. 2019. PMID: 31223045 Free PMC article.

4

Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers.

Song X, Zhou Z, Li H, Xue Y, Lu X, Bahar I, Kepp O, Hung MC, Kroemer G, Wan Y. Song X, et al. Among authors: wan y. Cancer Discov. 2020 Dec;10(12):1872-1893. doi: 10.1158/2159-8290.CD-20-0402. Epub 2020 Sep 16. Cancer Discov. 2020. PMID: 32938586 Free PMC article.

5

Exosomes as a Drug Delivery System in Cancer Therapy: Potential and Challenges.

Kibria G, Ramos EK, Wan Y, Gius DR, Liu H. Kibria G, et al. Among authors: wan y. Mol Pharm. 2018 Sep 4;15(9):3625-3633. doi: 10.1021/acs.molpharmaceut.8b00277. Epub 2018 May 30. Mol Pharm. 2018. PMID: 29771531 Free PMC article.

6

EIF3H Orchestrates Hippo Pathway-Mediated Oncogenesis via Catalytic Control of YAP Stability.

Zhou Z, Zhou H, Ponzoni L, Luo A, Zhu R, He M, Huang Y, Guan KL, Bahar I, Liu Z, Wan Y. Zhou Z, et al. Among authors: wan y. Cancer Res. 2020 Jun 15;80(12):2550-2563. doi: 10.1158/0008-5472.CAN-19-3718. Epub 2020 Apr 8. Cancer Res. 2020. PMID: 32269044 Free PMC article.

7

ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4.

Zou H, Chen H, Zhou Z, Wan Y, Liu Z. Zou H, et al. Among authors: wan y. Cancer Lett. 2019 Dec 28;467:19-28. doi: 10.1016/j.canlet.2019.09.012. Epub 2019 Sep 26. Cancer Lett. 2019. PMID: 31563563

8

A novel strategy to block mitotic progression for targeted therapy.

Chi JJ, Li H, Zhou Z, Izquierdo-Ferrer J, Xue Y, Wavelet CM, Schiltz GE, Zhang B, Cristofanilli M, Lu X, Bahar I, Wan Y. Chi JJ, et al. Among authors: wan y. EBioMedicine. 2019 Nov;49:40-54. doi: 10.1016/j.ebiom.2019.10.013. Epub 2019 Oct 25. EBioMedicine. 2019. PMID: 31669221 Free PMC article.

9

RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy.

Zhou Z, Qiao JX, Shetty A, Wu G, Huang Y, Davidson NE, Wan Y. Zhou Z, et al. Among authors: wan y. Cell Mol Life Sci. 2014 Apr;71(8):1549. doi: 10.1007/s00018-013-1376-3. Epub 2013 Jun 5. Cell Mol Life Sci. 2014. PMID: 23736835 Free PMC article. No abstract available.

10

Cullin 4-DCAF Proteins in Tumorigenesis.

Zhou Z, Song X, Wavelet CM, Wan Y. Zhou Z, et al. Among authors: wan y. Adv Exp Med Biol. 2020;1217:241-259. doi: 10.1007/978-981-15-1025-0_15. Adv Exp Med Biol. 2020. PMID: 31898232 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results